• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Message from the Acting Commissioner.

<< Return to FY 2006 Budget Summary


Image of Lester Crawford

I am pleased to submit the Food and Drug Administration's (FDA) FY 2006 budget that represents the Agency's resource requirements for the coming year. These resources will support our increasingly critical work to protect and advance the health of Americans, by ensuring the safety and security of food, medical products and animal drugs and feed while promoting innovation so that consumers may rapidly obtain more effective health-care products and information.

This request totaling $1,881,489,000, which includes budget authority and user fees, focuses on four areas that I will briefly highlight. First, the request funds the critical work involved with protecting the nation's food supply and will assist FDA in meeting the goals established by the White House Homeland Security Presidential Directive/HSPD-9, "Defense of the United States Agriculture and Food," which requires "enhancing screening procedures for domestic and imported products." Second, our request supports our medical device program and would be augmented with user fees, as well as agreed upon ambitious performance goals, to improve the quality and time required for innovative medical devices to reach the market. Third, the request will increase and enhance the Center for Drug Evaluation and Research's (CDER) Office of Drug Safety (ODS) review and analysis of both pre-marketing and post-marketing safety information on all products regulated by the Center. Finally, the budget request supports our ongoing move to the new Federal Research Center in White Oak, Maryland, where the General Services Administration is building FDA's consolidated modern laboratories and office campus.

To address these priorities as efficiently as possible, FDA has built on the significant progress in implementing the President's Management Agenda (PMA) and the Department of Health and Human Services' secretarial goal for administrative consolidation. A cornerstone of our recent successes in these managerial reforms is our reliance on the Shared Services Organization that is providing high quality service to our organizations. Another example of managerial reform can be seen in FDA's continued, concerted effort to trim its Information Technology costs. Our continuing efforts to improve FDA efficiency will allow us to redirect reform savings to national priority, mission-critical areas including food security, counterterrorism, medical countermeasures, bovine spongiform encephalopathy prevention, and patient safety.

I thank you for your continued support of the FDA in the FY 2006 budget.


 Lester M. Crawford, D.V.M., Ph.D.


<< Return to FY 2006 Budget Summary